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Background: Podocytic infolding glomerulopathy (PIG) is a recently described condition causing rare pathological
changes to the glomeruli, and has attracted considerable attention. PIG is characterized by specific changes to the
thickened glomerular basement membrane (GBM), including microspheres, microtubular structures, and podocytic
infolding. Only a small number of cases of PIG have been reported. The clinical features and pathogenesis of this
condition are still unclear. To elucidate the characteristics of this glomerulopathy, it is necessary to accumulate
information from reported cases. We present here the first reported case of PIG with multiple myeloma.
Case presentation: A 79-year-old Japanese man was admitted to his local hospital with proteinuria,
hypergammaglobulinemia, hypoalbuminemia, and kidney dysfunction. Laboratory tests revealed monoclonal IgG
(λ) M proteins in the serum and Bence-Jones proteins in the urine. Bone marrow aspiration showed monoclonal
plasma cell proliferation, indicating a diagnosis of multiple myeloma. Renal biopsy was performed to determine
the cause of the proteinuria and kidney dysfunction. Histological examination of the biopsy specimen showed
glomeruli with an irregularly thickened GBM and bubble-like structures in the capillary walls. Immunofluorescence
staining did not show glomerular deposition of immunoglobulins, light chains, or complement components.
Congo red staining did not show amyloid deposition. Electron microscopy showed an irregularly thickened GBM
with unusual structures in the glomerular capillary walls including podocytic infolding and microspheres,
suggesting PIG. There were no electron-dense deposits in the GBM, while various findings indicating podocyte
injury were detected.
Conclusion: We present here the first reported case of PIG in a patient with multiple myeloma. The mechanisms
underlying the development of PIG in multiple myeloma are unknown, but may be associated with podocyte
injury.
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Podocytic infolding glomerulopathy (PIG) was recently
described by Joh et al. [1] and has attracted considerable
attention because of the characteristic pathological
changes to the glomeruli. The glomerular changes are
characterized by specific lesions of the thickened glome-
rular basement membrane (GBM) including micro-
spheres, microtubular structures, and podocytic infolding
[1]. Patients with PIG always present with proteinuria, and
often have kidney dysfunction [1].* Correspondence: yujibeat@shinshu-u.ac.jp
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stated.PIG is not included in the current World Health
Organization classification of glomerular diseases. Only
a small number of cases of PIG have been reported to
date, and these have all been in Japan. These reports
show that PIG tends to be associated with autoimmune
abnormalities, such as systemic lupus erythematosus
(SLE). Although some specialists consider that PIG
should be classified as a new disease entity, it is also pos-
sible that PIG reflects a transient morphological change
in patients with conditions such as SLE and membra-
nous nephropathy. In addition, the clinical features and
pathogenesis of PIG are still unclear. To elucidate these
issues, it is important to accumulate information from
reported cases. We present here the first reported case
of PIG in a patient with multiple myeloma.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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A 79-year-old Japanese man presented with proteinuria,
hypoalbuminemia, and increasing kidney dysfunction, and
was admitted to his local hospital. He had a 3-year history
of hypertension, hyperlipidemia, and hyperuricemia with
mild kidney dysfunction (serum creatinine level 1.1 mg/dL
at age 76 years). He had been treated with an angiotensin
II receptor blocker, statin, and allopurinol for 3 years.
His proteinuria and hypoalbuminemia had gradually
worsened, with increasing serum creatinine levels. On ad-
mission, his blood pressure was 140/67 mmHg. Physical
examination revealed no leg edema. Laboratory tests
showed marked hypergammaglobulinemia with hypoalbu-
minemia (total protein 8.1 g/dL, albumin 3.3 g/dL), kidney
dysfunction (blood urea nitrogen 28 mg/dL, serum cre-
atinine 1.28 mg/dL), hyperuricemia (uric acid 9.8 mg/dL),
high levels of beta-2 microglobulin (5.9 mg/L) and IgG
(3076 mg/dL), and low levels of IgA (35 mg/dL) and IgM
(24 mg/dL). Pancytopenia and autoimmune abnormalities,
such as anti-nuclear antibody, rheumatoid factor, and
hypocomplementemia, were not detected. Urinalysis
showed proteinuria without hematuria (total urine protein
and albumin excretion, 1423 and 949 mg/day, respec-
tively), and a high concentration of a tubulointerstitial in-
jury marker (N-acetyl-beta-D-glucosaminidase 35.9 U/L).
Serum and urine immunofixation electrophoresis showedA
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Jones proteins in the urine. Bone marrow aspiration
showed plasma cell proliferation (plasma cell count 22%).
Considering these findings, the patient was diagnosed with
multiple myeloma. A renal biopsy was performed to deter-
mine the cause of the proteinuria and kidney dysfunction.
The biopsy specimen had 30 glomeruli, including one with
global sclerosis and three with adhesive lesions. Histo-
logical examination showed glomeruli with an irregularly
thickened GBM and a bubble-like appearance in the
capillary walls (Figure 1A, B). Immunofluorescence and
Congo red staining showed no glomerular deposition of
immunoglobulins (IgG, IgA, IgM), light chains (κ, λ),
complement components (C3, C4d, C1q), or amyloid pro-
tein. Surprisingly, electron microscopy showed podocytic
infolding and microspheres in the irregularly thickened
GBM (Figure 1C, D) as well as foot process flattening,
with formation of microvilli and increased actin filaments
in the foot processes (Figure 1C, D). There were no
electron-dense deposits in the GBM. These pathological
changes were similar to those of the glomerulopathy
recently described by Joh et al. [1], suggesting a diagnosis
of PIG. Although marked hyalinosis and severe intimal
thickening of the renal interlobular arteries were not ob-
served, there were focal tubulointerstitial lesions accom-
panied by tubular atrophy, as well as interstitial fibrosisB
D
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arance of the capillary walls (periodic-acid methenamine silver staining).
kened GBM, including podocytic infolding (arrows) and microspheres
s flattening was observed with formation of microvilli and increased
GBM.
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ischemic changes. However, there were no changes indi-
cating cast nephropathy or amyloidosis, which are often
associated with myeloma. The patient had many risk fac-
tors for atherosclerosis such as advanced age, hyperten-
sion, diabetes mellitus, hyperlipidemia, and hyperuricemia.
Therefore, we considered that the increasing kidney dys-
function resulted from glomerular dysfunction due to PIG
superimposed on underlying chronic renal ischemia. The
patient was discharged and was treated with a moderate
dose of corticosteroids (prednisolone 20 mg/day) after
confirmation of the final pathological diagnosis. His pro-
teinuria and his general condition slowly improved, but he
died suddenly from a severe acute pulmonary infection
2 months after the introduction of steroid therapy.
Discussion
PIG is a rare glomerulopathy characterized by unique
pathological changes in the glomerular capillary wall, in-
cluding podocytic infolding and microspheres in the GBM,
as found in the current case. The mechanisms underlying
the development of PIG are still unclear. Several previous
studies using immune electron microscopy found depo-
sition of complement components and/or complement
C5b-C9 complexes in extracellular organized structures,
which are morphologically similar to microspheres, in the
GBM in various kinds of glomerular diseases [2,3]. Further-
more, Fujigaki et al. analyzed the glomerular lesions of PIG
using immune electron microscopy, and detected comple-
ment C5b-C9 and vimentin (a component of podocytes) in
extracellular organized structures in the GBM [4]. These
pathological findings indicate an association between hy-
peractivation of the complement pathway and development
of the characteristic microstructures of PIG. The largest
clinical study of PIG, which included 25 patients, reported
a high incidence of autoimmune disease (SLE in 14 cases,
Sjögren’s syndrome in four cases, autoimmune thyroid dis-
ease in two cases, rheumatoid arthritis in one case, mixed
connective tissue disease in one case, and primary biliary
cirrhosis in one case), and reported that corticosteroid ther-
apy reduced the proteinuria [1]. These findings suggest that
immune abnormalities with hyperactivation of the comple-
ment pathway may play an important role in the pathogen-
esis of PIG. We present here the first reported case of PIG
in a patient with multiple myeloma. Previous studies re-
ported various functional abnormalities and hyperactivation
of the complement pathway in patients with multiple mye-
loma [5-8]. Lugassy et al. reported that the terminal com-
plement pathway activating C5b-C9, as well as the classical
and alternative complement pathways, are activated in the
early stage as well as the later stages of multiple myeloma
[9]. These complement pathway abnormalities may induce
PIG via a similar process to that causing PIG in auto-
immune diseases. In the current case, however, we did notdetect any autoimmune abnormalities or hypocomplemen-
temia by routine laboratory examinations, and there was no
glomerular deposition of complement components (C3,
C4d, C1q). It is therefore possible that hyperactivation of
the complement pathway did not play a significant role in
the development of PIG in the current case, and that PIG
may also result from other mechanisms.
Matsuo et al. reported a patient with podocytic infolding
lesions associated with focal segmental glomerulosclerosis
secondary to vesicoureteral reflux, suggesting that the
podocytic infolding lesions were a reaction to podocyte in-
jury [10]. They reported similar changes to those found in
our patient, with various pathological changes in the foot
process structures such as flattening, formation of micro-
villi, and increased actin filaments, suggesting podocyte
injury. This suggests that podocyte injury may result in
the development of PIG irrespective of complement acti-
vation. This new information may help to increase our un-
derstanding of the pathogenesis of PIG.
We considered the possibility that PIG is an unusual
type of membranous nephropathy associated with micro-
spherical particles that developed after resolution of im-
mune complex deposition in the GBM. To evaluate this
possibility, we compared the clinical characteristics of pa-
tients with PIG and idiopathic membranous nephropathy
(IMN) in previously reported Japanese studies. We found
that these two groups of patients had different background
characteristics. The mean age at the time of diagnosis was
41.8 years in patients with PIG and 59 years in patients
with IMN [1,11]. The male-to-female ratio was almost 1:3
in patients with PIG and almost 1:1 in patients with IMN
[1,11]. The mean urinary protein excretion was 2.2 g/day
in patients with PIG and 7.9 g/day in patients with IMN
[1,11]. The therapeutic responses also appeared to vary
between these two groups of patients. All reported cases
of nephrotic PIG associated with autoimmune disease
achieved complete remission with corticosteroid therapy,
whereas only 66.7% of cases of nephrotic IMN achieved
complete or incomplete remission with corticosteroid
therapy [1,12]. Although spontaneous remission may
occur in some cases of IMN, complete or incomplete re-
mission did not occur in any of the reported cases of
nephrotic PIG not associated with autoimmune disease
and not treated with corticosteroids [1]. These findings
suggest that PIG is strongly influenced by corticosteroid
therapy and by associated autoimmune disease, and that
the response to therapeutic intervention differs between
patients with PIG and IMN. We consider these findings to
indicate that PIG is a new disease entity that differs from
IMN.
Conclusion
We present here the first reported case of PIG in a pa-
tient with multiple myeloma. Although the pathogenesis
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injury may result in PIG. Further case reports should be
accumulated to increase our understanding of PIG.
Consent
The present study complied with the guidelines of the
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